These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 25542308

  • 1. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study.
    Filippi AR, Badellino S, Ceccarelli M, Guarneri A, Franco P, Monagheddu C, Spadi R, Ragona R, Racca P, Ricardi U.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):524-9. PubMed ID: 25542308
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
    Filippi AR, Badellino S, Guarneri A, Levis M, Botticella A, Mantovani C, Ragona R, Racca P, Buffoni L, Novello S, Ricardi U.
    Technol Cancer Res Treat; 2014 Feb 01; 13(1):37-45. PubMed ID: 23819496
    [Abstract] [Full Text] [Related]

  • 3. Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results.
    Carvajal C, Navarro-Martin A, Cacicedo J, Ramos R, Guedea F.
    J BUON; 2015 Feb 01; 20(1):158-65. PubMed ID: 25778311
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Widder J, Klinkenberg TJ, Ubbels JF, Wiegman EM, Groen HJ, Langendijk JA.
    Radiother Oncol; 2013 Jun 01; 107(3):409-13. PubMed ID: 23773410
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Helou J, Thibault I, Poon I, Chiang A, Jain S, Soliman H, Erler D, Yeung L, Cheung P.
    Int J Radiat Oncol Biol Phys; 2017 Jun 01; 98(2):419-427. PubMed ID: 28463162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
    Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M.
    Lung Cancer; 2015 Jul 01; 89(1):50-6. PubMed ID: 25997421
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
    Lee DS, Kim YS, Yoo IeR, Kang YN, Kim SJ, Oh JK, Kim YK, Wang YP, Park JG, Kang JH, Han DH, Ahn MI, Lee KY.
    Lung Cancer; 2013 May 01; 80(2):172-8. PubMed ID: 23489556
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.